Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Astrazeneca Plc ADR NASDAQ: AZN-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 57.98
Day High 58.46
Open:58.20
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Worldwide Nanomedicines Industry to 2026 - Featuring 3M, Thermo Fisher Scientific and Eli Lily & Co Among Others
- PR Newswire - PRF - Tue Jun 15, 7:45AM CDT
PR Newswire - PRF - CMTX
Tue Jun 15, 7:45AM CDT
/PRNewswire/ -- The report has been added to offering.
Nearly $ 30 Billion growth expected in Global Type 2 Diabetes Market during 2021-2025 | Technavio
- PR Newswire - PRF - Mon Jun 14, 10:11AM CDT
PR Newswire - PRF - CMTX
Mon Jun 14, 10:11AM CDT
/PRNewswire/ - The type 2 diabetes market is expected to grow by during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the type 2 diabetes market in optimistic, probable, and pessimistic forecast scenarios.
$ 3.65 Growth expected in Global Diabetic Pens Market 2021-2025 | Featuring Major Vendors Including AstraZeneca Plc, Becton, Dickinson and Co. and Biocon Ltd. | Technavio
- PR Newswire - PRF - Thu Jun 10, 4:30PM CDT
PR Newswire - PRF - CMTX
Thu Jun 10, 4:30PM CDT
/PRNewswire/ --
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 55.73 +4.63% increase
on 06/03/21
Period Open:57.40
Price movement based on the high, low and last over the given period.
59.34 -1.74% decrease
on 06/16/21
+0.91 (+1.59%) increase
since 05/21/21
3-Month 48.26 +20.82% increase
on 04/07/21
Period Open:49.21
Price movement based on the high, low and last over the given period.
59.34 -1.74% decrease
on 06/16/21
+9.10 (+18.49%) increase
since 03/19/21
52-Week 46.48 +25.45% increase
on 03/04/21
Period Open:53.02
Price movement based on the high, low and last over the given period.
64.94 -10.21% decrease
on 07/20/20
+5.29 (+9.98%) increase
since 06/19/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies